BlackRock’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

BlackRock’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-733,214	Closed	-$7.47M	–	5539
2023 Q3	$7.47M	Buy	733,214 +71,659	+11%	+$546K	﹤0.01%	3489
2023 Q2	$3.11M	Buy	661,555 +81,844	+14%	+$376K	﹤0.01%	3883
2023 Q1	$2.68M	Buy	579,711 +20,833	+4%	+$91.7K	﹤0.01%	3916
2022 Q4	$2.03M	Buy	558,878 +48,956	+10%	+$217K	﹤0.01%	4125
2022 Q3	$2.41M	Buy	509,922 +29,520	+6%	+$148K	﹤0.01%	4092
2022 Q2	$2.33M	Buy	480,402 +306,894	+177%	+$1.87M	﹤0.01%	4190
2022 Q1	$1.1M	Buy	173,508 +76,907	+80%	+$414K	﹤0.01%	4632
2021 Q4	$600K	Buy	+96,601	New	+$755K	﹤0.01%	4826

BlackRock's THRN Position: Q4 2023 in Review

BlackRock sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 733,214 shares — an estimated $7.47M sold.

BlackRock first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $7.47M in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

BlackRock reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
BlackRock sold 733,214 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $7.47M.
BlackRock first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
BlackRock's Thorne Healthtech, Inc. Common Stock position peaked at $7.47M in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.